Search

everythinglearnresearchcommunity

for

Search:↓

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

DM and AA may share a common cause.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tiny particles from skin cells can help activate hair growth.

HIV can cause unusual and severe skin problems that are hard to treat.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

FOXN1 gene variants cause low T cells and immune issues from birth.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

FoxN1 overexpression in young mice harms immune cell and skin development.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.